Key facts
- It has raised $13.7M; the latest was Early Stage VC in Aug 2025.
- Notable investors include Cowin Capital, Fortune Capital, Pudong Capital, Chengrong Investment, Everest VC — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Hantong Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hantong Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hantong Medical
Manufacturer of active interventional medical devices aims to advance vascular interventional ultrasound therapies and provide innovative treatment solutions for major cardiovascular and chronic diseases. The company's offerings feature a fully self-developed ultrasound energy platform, high-frequency high-power ultrasound transducers, ablation catheters, and intravascular ultrasound-assisted thrombolysis systems, helping healthcare providers reduce costs, improve treatment outcomes, and bring new hope to patients suffering from hypertension, pulmonary embolism, and other critical conditions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2022
- Website
- hantongmed.com/
- Ownership
- Privately Held (backing)
Hantong Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hantong Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hantong Medical in its N-PORT filings yet. We sweep new filings monthly.